Lasa Supergenerics has reported results for first quarter ended June 30, 2021.
The company has reported 84.92% fall in its net profit at Rs 0.81 crore for the quarter under review as compared to net profit of Rs 5.37 crore for the same quarter in the previous year. Total income of the company decreased by 33.96% at Rs 36.08 crore for Q1FY22 as compared Rs 54.63 crore for the corresponding quarter previous year.
Lasa Supergenerics is pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.
